Cargando…
HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
OBJECTIVE: To study the influence of glycosylated haemoglobin (HbA1c) on response of bevacizumab in patients with diabetic macular oedema. METHODS AND ANALYSIS: A total of 37 eyes of 37 patients with vision loss due to diabetic macular oedema treated with bevacizumab were included in this study. Par...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228525/ https://www.ncbi.nlm.nih.gov/pubmed/32426522 http://dx.doi.org/10.1136/bmjophth-2020-000449 |